BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 8, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 30, 2012
View Archived Issues
U.S. university researchers disclose novel beta-amyloid production inhibitors
Read More
Pierre Fabre discloses new monoclonal antibodies for cancer
Read More
Novartis reflects on accomplishments of 2011
Read More
Novel phosphodiesterase 10A inhibitors prepared by Lundbeck
Read More
Merck KGaA patents new TGF-beta receptor type-1 inhibitors
Read More
Janssen Pharmaceutica synthesizes novel beta-secretase 1 inhibitors
Read More
Scientists at Cellzome patent novel TYK2 inhibitors
Read More
Histone deacetylase inhibitors may have potential in treating Gaucher's disease
Read More
Experiments delineate antiseizure activity of valpromide homolog
Read More
GenVec extends licensing and collaboration agreement with Novartis
Read More
Swissmedic grants marketing authorization for transdermal estradiol spray
Read More
Amgen enters definitive merger agreement
Read More
Cancer Research UK begins study of AT-9283
Read More
Indication for Gadovist 1.0 is expanded
Read More
FDA accepts bosutinib NDA for review
Read More
Infinity Pharmaceuticals completes preliminary analysis of saridegib/gemcitabine combination study
Read More
FDA approves axitinib for advanced renal cell carcinoma
Read More
Cell Therapeutics withdraws Pixuvri NDA
Read More
FDA approves first-ever once-weekly treatment for type 2 diabetes
Read More
European Commission requests further information in Glybera review
Read More
IDMC reviews Ziopharm's study of palifosfamide in metastatic soft tissue sarcoma
Read More
Amgen offers pipeline update for 2011
Read More
MT-110 shows promise in models of pancreatic cancer
Read More
Overseas trials begin for Pro-Rvlysin prostate cancer treatment
Read More
Navidea Biopharmaceuticals enters into agreement for Parkinson's disease imaging agent
Read More